B2M is a part of the constant region of major histocompatibility class I (MHC I) that is constitutively expressed on all nucleated cells, while PD-L1 is conditionally expressed in monocytes and MDMs and has been reported to regulate other immune cells in the tumor microenvironment3. This evidence concerns the gene B2M and neoplasm.